Cargando…
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
PURPOSE: Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has...
Autores principales: | Arana, Alejandro, Margulis, Andrea V, Varas‐Lorenzo, Cristina, Bui, Christine L, Gilsenan, Alicia, McQuay, Lisa J, Reynolds, Maria, Rebordosa, Cristina, Franks, Billy, de Vogel, Stefan, Appenteng, Kwame, Perez‐Gutthann, Susana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821285/ https://www.ncbi.nlm.nih.gov/pubmed/33091194 http://dx.doi.org/10.1002/pds.5150 |
Ejemplares similares
-
Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study
por: Arana, Alejandro, et al.
Publicado: (2018) -
Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom
por: Margulis, Andrea V., et al.
Publicado: (2018) -
Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom
por: Margulis, Andrea V., et al.
Publicado: (2018) -
Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias
por: Kaye, James A., et al.
Publicado: (2017) -
Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study
por: Arana, Alejandro, et al.
Publicado: (2015)